Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Pharem Biotech AB
AB
Active
Org 5569230955
Kistagången 12, 164 40
Kista
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2013 · 13 years old
6 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Pharem Biotech AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
EO
Erik Oskar Wall
Chief Auditor
Chief Auditor
2020
MA
Martin Alexander Ryen
Chief Executive Officer
Chief Executive Officer
2020
Former (1)
BS
Björn Sture Bernhard Peters Ohlsson
Chief Auditor
Chief Auditor
2020 – 2020
Board of directors
Non-executive oversight
Name
Role
Member since
Current (5)
BT
Bernt Torsten Mikael Fryklund
Board of Directors
Board of Directors
2025
MA
Martin Alexander Ryen
Board of Directors
Board of Directors
2020
BC
Björn Christian Ryen
Chairman
Chairman
2025
HK
Helge Kuno Ryen
Deputy Board Member
Deputy Board Member
2020
TS
Tor Simon Angeldorff
Board of Directors
Board of Directors
2020
Former (3)
SP
Svante Pålsson Horn af Åminne
Board of Directors
Board of Directors
2020 – 2025
KM
Kurt Michael Grimborg
Board of Directors
Board of Directors
2020 – 2021
KM
Karl Mathias Johansson
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Pharem Biotech AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
Board of Directors
Board of Directors
2022 – 2025
